Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT 3 Receptors

Gerhard Rammes, Christine Hosp, Brigitte Eisensamer et al. · 2009

Read Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT 3 Receptors by Gerhard Rammes, Christine Hosp, Brigitte Eisensamer et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006715.txt.

Description

Gerhard Rammes and colleagues pinpointed a receptor region that changes how clozapine acts in PLOS ONE in 2009. Clozapine is a widely used drug for schizophrenia. It also strongly blocks serotonin 5-HT3 receptors. That blocking may contribute to its unusual clinical profile. The drug binds these receptors in several species.

The team searched for the domain that controls two drug properties. One property is kinetics, meaning how fast the drug acts and fades. The other is antagonistic potency, meaning how strongly it blocks. Finding the controlling region explains species differences in clozapine action. It may also guide design of cleaner drugs aimed at the same receptor.

Catalog record

CREATORGerhard Rammes, Christine Hosp, Brigitte Eisensamer et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006715

Browse the full library · About the Tower of Babel